openPR Logo
Press release

Anti-tuberculosis Therapeutics Market Estimated to Rise Profitably with CAGR 6% during 2019 – 2023 | Global Key Players (ASTRAZENECA, BAYER AG, ELI LILLY AND COMPANY, GLAXOSMITHKLINE, LUPIN PHARMACEUTICALS, NOVARTIS AG)

01-24-2019 04:48 PM CET | Health & Medicine

Press release from: Market Prognosis

The global anti-tuberculosis Therapeutics market is expected to register a CAGR of 6.0% during the forecast period, 2018 to 2023. North America dominates the market, due to growing awareness regarding tuberculosis among the people.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/16766
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Rising Prevalence of Tuberculosis (TB)
Rising prevalence of tuberculosis, especially in developing countries, is the major driver for the growth of the global anti-tuberculosis Therapeutics market. According to World Health Organization (WHO), in 2016, 10.4 million new tuberculosis cases were reported. Around 1.7 million TB patients died from the disease (which includes 0.4 million among people with HIV). Over 95% of TB deaths occur in low- and middle-income countries. Growing prevalence of pedriatic tuberculosis and increasing incidence of multi-drug-resistant tuberculosis (MDR TB) and extensively drug-resistant (XDR) TB cases are further driving the growth of the global tuberculosis Therapeutics market.
Also, growing initiative from government organization regarding awareness of tuberculosis, a collaboration between academic and private players for novel antibiotics drug development is another factor driving the growth of the global anti-tuberculosis drugs market.

Key Developments in the Market
• August 2016: Mylan Inc., received approval from Drug Controller General of India (DCGI) regulatory body in India, to market anti-TB drug Delamanid in India.
• August 2017: Johnson & Johnson entered into a partnership with the Institute of Microbial Technology (IMTECH), part of the Council of Scientific and Industrial Research (CSIR), to accelerate the discovery of a novel treatment for tuberculosis.

Major Players:
ASTRAZENECA PLC, BAYER AG, ELI LILLY AND COMPANY, GLAXOSMITHKLINE PLC, LUPIN PHARMACEUTICALS INC., NOVARTIS AG, PFIZER INC., SANDOZ INTERNATIONAL GMBH, SANOFI, AND JOHNSON & JOHNSON, among others.

Request Discount on this report @ https://marketprognosis.com/discount-request/16766
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

High Cost of TB Therapeutics and Lack of Insurance Coverage in Low-and Middle-income Countries
Tuberculosis (TB) treatment is done over a long period, and continuous medicine and monitoring is needed during the treatment. This results in overall high treatment costs. According to reseach, on an average, the total cost of TB treatment was equivalent to 58% (5%-306%) of the reported annual individual income, and 39% (4%-148%) of the reported household income. This financial burden varies between countries, owing to varying healthcare settings, TB care models, general health systems, and social protection schemes. The financial burden is on an average more for persons suffering from MDR-TB and for the poorest. However, most of the low- and-middle income countries, such as Asian and African countries, have limited insurance coverage. Thus, high u2018out-of-pocket’ treatment cost, coupled with adverse side effects of anti-tuberculosis drugs, is expected to limit this market, as a large share of the population will not be able to afford the treatment. Factors, such as adverse side effects of anti-tuberculosis drugs, also hinder the market.

Asia-Pacific to Show High Growth Rate
North America dominates the global anti-tuberculosis Therapeutics market, owing to the presence of well-established market players, and raising awareness regarding tuberculosis. Asia-Pacific is expected to grow tremendously during the forecast period, owing to factors, such as high prevalence of tuberculosis and growing government initiative to create awareness regarding tuberculosis.

Enquiry Before Buying@ https://marketprognosis.com/enquiry/16766
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMarkPvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-tuberculosis Therapeutics Market Estimated to Rise Profitably with CAGR 6% during 2019 – 2023 | Global Key Players (ASTRAZENECA, BAYER AG, ELI LILLY AND COMPANY, GLAXOSMITHKLINE, LUPIN PHARMACEUTICALS, NOVARTIS AG) here

News-ID: 1531001 • Views:

More Releases from Market Prognosis

Third-Party Logistics (3PL) Market Latest Study Focuses On Current, Future Innovations and Foreseen Till 2026 | FedEx, Exel Logistics, Menlo Worldwide Logistics, Ryder Logistics
Third-Party Logistics (3PL) Market Latest Study Focuses On Current, Future Innov …
The report covers a forecast and an analysis of the Third-Party Logistics (3PL) Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume. Overview of the Global Third-Party Logistics (3PL) Market: The report spread across 90 pages is an overview of the Global Third-Party Logistics (3PL) Market. These report study based on the Third-Party
Ride-Hailing Market: An Insight on the Important Factors and Trends Influencing by Top Key Players (Didi, Uber, Lyft, Gett, Hailo, Ola Cabs, Cabify, GoCatch) | Foreseen Till 2026
Ride-Hailing Market: An Insight on the Important Factors and Trends Influencing …
The report covers a forecast and an analysis of the Ride-Hailing Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume. Overview of the Global Ride-Hailing Market: The report spread across 90 pages is an overview of the Global Ride-Hailing Market. These report study based on the Ride-Hailing Market. It is a complete overview
COVID-19 Impact on Professional Indemnity Insurance Market 2021-2026: Industry Insight and Growth Strategy by Business Players - AIG, Chubb (ACE), Allianz, XL Group, AXA, Aviva
COVID-19 Impact on Professional Indemnity Insurance Market 2021-2026: Industry I …
The report covers a forecast and an analysis of the Professional Indemnity Insurance Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume. Overview of the Global Professional Indemnity Insurance Market: The report spread across 90 pages is an overview of the Global Professional Indemnity Insurance Market. These report study based on the Professional
Modular Construction Market Future Growth Explored in Latest Research Report by 2026 | Komatsu, Kiewit, Skanska, L&T, Taisei, ACS Group, Bouygues Construction
Modular Construction Market Future Growth Explored in Latest Research Report by …
The report covers a forecast and an analysis of the Modular Construction Market on a global and regional level. The study provides historical data for 2018, 2019, and 2020 along with a forecast from 2019 to 2026 based on revenue and volume. Overview of the Global Modular Construction Market: The report spread across 90 pages is an overview of the Global Modular Construction Market. These report study based on the Modular Construction Market. It

All 5 Releases


More Releases for Therapeutics

Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant
Pruritus Drug Market – Key Players are Cara Therapeutics, Enteris BioPharma, N …
The Pruritus Drug Market research report is a significant investigation of changing business sector elements, driving elements, impediments, and limitations that have been considered the most extensive impacts on market development. Adroit investigative devices, for example, Porter’s Five Forces examination, SWOT examination, and Feasibility examination study have likewise been utilized by the report to offer an exhaustive information of the market. It will go about as a key research report
Dravet Syndrome Therapeutics- Pipeline Analysis 2018 | Zogenix, Inc., Ovid Thera …
Dravet syndrome is a form of severe myoclonic epilepsy that occurs in infants during their first year of age. If left untreated, it can be associated with other types of seizures, and status epilepticus. Children having Dravet syndrome are generally observed with poor cognitive skills and hyperactivity. Download the sample report @ https://www.pharmaproff.com/request-sample/1098 It severely affects the person’s quality of life and around 10-20% of the patient are estimated to die due
Global mRNA Cancer Vaccines and Therapeutics Market to 2025| Moderna Therapeutic …
Researchmoz added Most up-to-date research on "Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2019-2025" to its huge collection of research reports. mRNA Cancer Vaccines and Therapeutics Market report includes (6 Year Forecast 2019-2025) includes Overview, classification, industry value, price, cost and gross profit. It also offers in-intensity insight of the mRNA Cancer Vaccines and Therapeutics industry masking all vital parameters along with, Drivers, Market Trends, Market Dynamics,
Global Pruritus Therapeutics Market Report 2019 Companies included Actavis, Trev …
Market Reports Company has recently published 7th edition of Pruritus Therapeutics Market Report which covers historic data of year 2013 to 2018 along with a forecast till year 2026. For inquiry or free sample pages email us at: sales@marketreportscompany.com The report provides a comprehensive view on the current state and future prospects of the market which analyzes different strategies for business growth. The global Pruritus Therapeutics market was valued at USD xx
MRNA Vaccines & Therapeutics Market 2019 Global Analysis By Key Players – Mode …
WiseGuyReports.Com Publish a New Market Research Report On –“ MRNA Vaccines & Therapeutics Market 2019 Global Analysis By Key Players – Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics”. Description:- The mRNA Vaccines & Therapeutics industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, mRNA Vaccines & Therapeutics market size to maintain the average annual growth rate of XXX from